US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HLS Therapeutics Inc.

3.36

0.0000

Volume:- -

Turnover:- -

Market Cap:106.89M

PE:-5.90

High:3.36

Open:3.36

Low:3.36

Close:3.36

52wk High:4.02

52wk Low:2.73

Shares:31.79M

Float Shares:19.29M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5699

EPS(LYR):-0.6173

ROE:-20.02%

ROA:-1.86%

PB:1.73

PE(LYR):-5.45

Loading ...

Overview Company News Filings

Company Profile

Company Name:

HLS Therapeutics Inc.

Exchange:

PINK LIMITED

Establishment Date:

- -

Employees:

92

Office Location:

10 Carlson Court,Suite 701,Etobicoke,Ontario,Canada

Website:

http://www.automodular.com

Zip Code:

M9W 6L2

Phone:

Fax:

416 213 0045

Introduction:

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. schizophrenia. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HLTRF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"HLTRF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HLTRF\",,,,,undefined,":{"symbol":"HLTRF","market":"US","secType":"STK","nameCN":"HLS Therapeutics Inc.","latestPrice":3.362,"timestamp":1771966800000,"preClose":3.362,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":19290456,"shares":31793047,"eps":-0.569853,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-24 16:00:00 EST Delay","open":3.362,"high":3.362,"low":3.362,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.569853,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":3.362,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HLTRF\",,,,,undefined,":{"symbol":"HLTRF","floatShares":19290456,"roa":"-1.86%","roe":"-20.02%","lyrEps":-0.617315,"shares":31793047,"dividePrice":0,"high":3.362,"amplitude":0,"preClose":3.362,"low":3.362,"week52Low":2.7325,"pbRate":"1.73","psRate":"1.91","week52High":4.02,"institutionHeld":0,"latestPrice":3.362,"eps":-0.569853,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.569853,"open":3.362,"prevYearClose":3.43,"prevWeekClose":3.362,"prevMonthClose":3.362,"prevQuarterClose":3.43,"fiveDayClose":3.362,"twentyDayClose":3.362,"sixtyDayClose":3.467},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HLTRF\",params:#limit:5,,,undefined,":[{"date":"2024-05-09","symbol":"HLTRF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715241600000,"name":null,"time":"Pre-Market","dateTimestamp":1715227200000,"actualEps":null},{"market":"US","date":"2023-04-27","symbol":"HLTRF","amount":0.05,"defaultRemindTime":1682602200000,"name":"HLS Therapeutics Inc.","recordDate":"2023-06-15","payableDate":"2023-04-28","currency":"CAD","type":"dividend","dateTimestamp":1682568000000},{"market":"US","date":"2023-01-30","symbol":"HLTRF","amount":0.05,"defaultRemindTime":1675089000000,"name":"HLS Therapeutics Inc.","recordDate":"2023-03-15","payableDate":"2023-01-31","currency":"CAD","type":"dividend","dateTimestamp":1675054800000},{"date":"2022-11-10","symbol":"HLTRF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1668070800000,"name":null,"time":"Pre-Market","dateTimestamp":1668056400000,"actualEps":null},{"market":"US","date":"2022-10-28","symbol":"HLTRF","amount":0.05,"defaultRemindTime":1666963800000,"name":"HLS Therapeutics Inc.","recordDate":"2022-12-15","payableDate":"2022-10-31","currency":"CAD","type":"dividend","dateTimestamp":1666929600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HLTRF\",market:\"US\",,,undefined,":[{"executeDate":"2019-01-30","recordDate":"2019-01-31","paymentDate":"2019-03-15","value":0.05,"currency":"CAD"},{"executeDate":"2019-04-29","recordDate":"2019-04-30","paymentDate":"2019-06-14","value":0.05,"currency":"CAD"},{"executeDate":"2019-07-30","recordDate":"2019-07-31","paymentDate":"2019-09-13","value":0.05,"currency":"CAD"},{"executeDate":"2019-10-30","recordDate":"2019-10-31","paymentDate":"2019-12-13","value":0.05,"currency":"CAD"},{"executeDate":"2020-01-30","recordDate":"2020-01-31","paymentDate":"2020-03-13","value":0.05,"currency":"CAD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HLTRF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1756011600000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":303684187,"employeeNum":92,"address":"10 Carlson Court,Suite 701,Etobicoke,Ontario,Canada","zipCode":"M9W 6L2","officePhone":"647 495 9000","officeFax":"416 213 0045"},"stockCompanyDetail":{"websiteUrl":"http://www.automodular.com","stockEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":-0.1809},{"period":"3month","weight":-0.1809},{"period":"6month","weight":-0.1024},{"period":"1year","weight":-0.0081},{"period":"ytd","weight":-0.049}],"description":"HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. schizophrenia. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.","exchange":"PINK LIMITED","name":"HLS Therapeutics Inc.","nameEN":"HLS Therapeutics Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"HLTRF\",market:\"US\",,,undefined,":null}}